Antimicrobial resistance in Haemophilus influenzae isolated during population-based surveillance for meningitis in Salvador, Brazil

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3641-3643

  Reis, Joice Neves ^a   Lima, Josilene Borges ^a   Ribeiro, Guilherme Souza ^a   Corderio, Soraia Machado ^a   Salgado, Kátia ^a   Reis, Mitermayer Galvão ^a   Ko, Albert I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BRAZIL; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BETA-LACTAMASES; BRAZIL; COST-BENEFIT ANALYSIS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; MENINGITIS, HAEMOPHILUS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE;

EID: 0036838648     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3641-3643.2002     Document Type: Article

References (14)

1. Barry, A. L., P. C. Fuchs, and M. A. Pfaller. 1993. Susceptibilities of β-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 37:14-18.
2. Critchley, I. A., C. Thornsberry, G. Piazza, M. Jones, M. L. Hickey, A. L. Barth, C. Mendes, F. F. Rossi, H. S. Sader, L. M. Teixeira, and D. F. Sahm. 2000. Antimicrobial susceptibility of Streptococcus pneumoniae Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98. Clin. Microbiol. Infect. 6:178-184.
3. De Andrade, A. L., M. C. Brandileone, J. L. Di Fabio, R. M. Oliveira, S. A. Silva, S. S. Baiocchi, and C. M. Martelli. 2001. Haemophilus influenzae resistance in Latin America: systematic review of surveillance data. Microb. Drug Resist. 7:403-411.
4. Di Fablo, J. L., E. Castaneda, C. I. Agudelo, F. De La Hoz, M. Hortal, T. Camou, G. Echaniz-Aviles, M. Noemi, C. Barajas, I. Heitmann, J. C. Hormazabal, M. C. Brandileone, V. S. Dias Vieira, M. Regueira, R. Ruvinski, A. Corso, M. Lovgren, J. A. Talbot, C. De Quadros, et al. 2001. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. Pediatr. Infect. Dis. J. 20:959-967.
5. Hart, C. A., and S. Kariuki. 1998. Antimicrobial resistance in developing countries. BMJ 317:647-650.
6. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32 (Suppl. 2):S81-S93.
7. Lopez-Vidal, Y., E. Palavecino, and F. Rossi. 2002. Prevalence of betalactamase production in H. influenzae isolated in Latin America in 1998-1999: results of the LASER study. Int. J. Antimicrob. Agents 19:201-205.
8. Mendelman, P. M., D. O. Chaffin, T. L. Stull, C. E. Rubens, K. D. Mack, and A. L. Smith. 1984. Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26:235-244.
9. Ministério da Saúde. 1998. Guia de Vigilância Epidemiológica-Meningites em geral. Ministério da Saúde, Fundação Nacional de Saúde, Brasilia, Brazil.
10. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.
12. Rojo, P. 2001. Access to essential drugs in developing countries. Gac. Sanit. 15:540-545. (In Spanish.)
13. Ubukata, K., N. Chiba, K. Hasegawa, Y. Shibasaki, K. Sunakawa, M. Nonoyama, S. Iwata, and M. Konno. 2002. Differentiation of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method. J. Infect. Chemother. 8:50-58.
14. Zanella, R. C., S. T. Casagrande, S. Bokermann, S. C. Almeida, and M. C. Brandileone. 2002. Characterization of Haemophilus influenzae isolated from invasive disease in Brazil from 1990 to 1999. Microb. Drug Resist. 8:67-72.